5PDCell-based immunotherapy combining encapsulation cell technology and irradiated autologous tumor cells: A novel technology platform that is both safe and feasible. Results from first in man trial
2015
Files
Details
Title
5PDCell-based immunotherapy combining encapsulation cell technology and irradiated autologous tumor cells: A novel technology platform that is both safe and feasible. Results from first in man trial
Author(s)
Mach, N. ; Migliorini, D. ; Vernet, R. ; Belkouch, M.-C. ; Luy, P. ; Ancrenaz, V. ; Py, C. ; Grogg, J. ; Harboe-Schmidt, P. ; Bouche, N.
Published in
Annals of Oncology
Volume
26
Pages
viii2-viii2
Date
2015
Publisher
Oxford, Oxford University Press
ISSN
0923-7534
1569-8041
1569-8041
Note
National Licences
Laboratories
LEN
Record Appears in
Scientific production and competences > SV - School of Life Sciences > SV Archives > LEN - Neurodegenerative Studies Laboratory
Peer-reviewed publications
Work produced at EPFL
Journal Articles
Published
Peer-reviewed publications
Work produced at EPFL
Journal Articles
Published
Record creation date
2019-08-23